Honey for Coughs: The Strongest Evidence Manuka Has

The clearest indication

Most of the literature on manuka honey is in vitro: bacterial cultures in petri dishes, biofilm assays, MIC measurements. The translation from those numbers to a measurable outcome in a human is rarely direct.

The one indication where the gap closes is upper respiratory symptom relief, particularly cough. The evidence here is not specific to manuka. It is honey-class evidence. But it is the strongest clinical literature in the category.

The 2021 BMJ EBM meta-analysis

Abuelgasim and colleagues published a systematic review and meta-analysis in BMJ Evidence-Based Medicine in 2021 covering 14 studies and over 1700 participants. The headline result: honey was superior to usual care in reducing both the frequency and severity of cough symptoms in upper respiratory tract infections. Across the included trials, honey performed better than no treatment, better than placebo, and comparably to or better than over-the-counter cough preparations.

The authors' framing is worth quoting. They concluded that honey provides "a widely available and cheap alternative to antibiotics" for upper respiratory infections, where antibiotics are typically inappropriate but patients often expect treatment. The analysis did not differentiate manuka from non-manuka honey because most included trials used generic honey.

The 2023 paediatric review

A 2023 systematic review in the European Journal of Paediatrics looked specifically at honey for acute cough in children over 12 months. It found honey performed better than diphenhydramine (a standard pediatric cough antihistamine) and at least as well as dextromethorphan (the most common over-the-counter cough suppressant).

This review explicitly addressed the question paediatricians get asked: should I give my coughing toddler honey or cough syrup. The answer, on current evidence, is that honey is at least as effective and does not carry the side-effect or behavioural-disruption profile of the OTC products.

Why honey works for this

Three mechanisms are commonly cited and all are plausible:

Viscosity. Honey is a thick, sticky liquid that coats the throat, providing mechanical demulcent action. This alone reduces cough-trigger irritation.

Antibacterial activity. Most upper respiratory infections are viral, but secondary bacterial colonization of inflamed tissue is common. Honey's broad antibacterial activity may reduce that secondary load.

Sweetness. The sensory experience of honey appears to suppress the cough reflex through pharyngeal stimulation. This is not trivial; it is one of the documented mechanisms by which dextromethorphan and other cough suppressants are thought to work.

Manuka may add to this picture through its non-peroxide antibacterial activity, which is heat-stable and unaffected by saliva. But the studies that would isolate that contribution against generic honey have not been done at scale.

Dosing in practice

The trials use one to two teaspoons of honey, typically taken straight or stirred into warm water, in the 30 minutes before sleep. For children over 12 months, half a teaspoon to one teaspoon depending on age. Repeat as needed up to two or three times a day during acute symptoms.

For manuka specifically, UMF 10+ or higher is the range used in any trials that did standardize the honey grade. For pure cough relief, there is no published evidence that a higher grade outperforms a lower one. For sore throat with apparent infection, higher grades are not unreasonable but lack specific RCT support.

The non-negotiable warning

No honey of any kind should be given to infants under 12 months. Honey, including manuka, can contain Clostridium botulinum spores at low levels. Adult and toddler digestive systems destroy them; infant digestive systems do not. Infant botulism is rare but serious, and honey is the only food where the link is well-established. This is a hard rule with no exceptions.

Why this matters for the broader manuka picture

Most of the manuka category is built on indications where the in vitro story is strong but the clinical evidence is thin. Cough and upper respiratory symptoms are the inverse: the clinical evidence is solid, and honey delivers what people are paying for. It is the only manuka indication where buying a jar is unlikely to be a wasted purchase.

That is worth holding onto when reading the broader marketing of the category. The claims that hold up best are often the most modest ones.